Heterogeneity in α-synuclein fibril activity correlates to disease phenotypes in Lewy body dementia
- 28 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Neuropathologica
- Vol. 141 (4), 547-564
- https://doi.org/10.1007/s00401-021-02288-1
Abstract
α-Synuclein aggregation underlies pathological changes in Lewy body dementia. Recent studies highlight structural variabilities associated with α-synuclein aggregates in patient populations. Here, we develop a quantitative real-time quaking-induced conversion (qRT-QuIC) assay to measure permissive α-synuclein fibril-templating activity in tissues and cerebrospinal fluid (CSF). The assay is anchored through reference panels of stabilized ultra-short fibril particles. In humanized α-synuclein transgenic mice, qRT-QuIC identifies differential levels of fibril activity across the brain months before the deposition of phosphorylated α-synuclein in susceptible neurons. α-Synuclein fibril activity in cortical brain extracts from dementia with Lewy bodies (DLB) correlates with activity in matched ventricular CSF. Elevated α-synuclein fibril activity in CSF corresponds to reduced survival in DLB. α-Synuclein fibril particles amplified from cases with high fibril activity show superior templating in the formation of new inclusions in neurons relative to the same number of fibril particles amplified from DLB cases with low fibril activity. Our results highlight a previously unknown broad heterogeneity of fibril-templating activities in DLB that may contribute to disease phenotypes. We predict that quantitative assessments of fibril activities in CSF that correlate to fibril activities in brain tissue will help stratify patient populations as well as measure therapeutic responses to facilitate the development of α-synuclein-targeted therapeutics.Funding Information
- National Institute of Neurological Disorders and Stroke (P50 NS108675, R01 NS064934)
This publication has 52 references indexed in Scilit:
- Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic MiceScience, 2012
- Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated α-synuclein gene mutations precede central nervous system changesHuman Molecular Genetics, 2010
- Fibril Fragmentation Enhances Amyloid CytotoxicityJournal of Biological Chemistry, 2009
- Low sensitivity in clinical diagnoses of dementia with Lewy bodiesZeitschrift für Neurologie, 2009
- Ultrasonication-dependent production and breakdown lead to minimum-sized amyloid fibrilsProceedings of the National Academy of Sciences of the United States of America, 2009
- Characterization of the nanoscale properties of individual amyloid fibrilsProceedings of the National Academy of Sciences of the United States of America, 2006
- Nature designs tough collagen: Explaining the nanostructure of collagen fibrilsProceedings of the National Academy of Sciences of the United States of America, 2006
- Protein Misfolding, Functional Amyloid, and Human DiseaseAnnual Review of Biochemistry, 2006
- Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formationMolecular and Cellular Neuroscience, 2003
- The cDNA cloning and ontogeny of mouse α-synucleinNeuroReport, 1998